Influence of Age on Antibody Response and Persistence Following Immunization With MenAfriVac

Background. A meningococcal group A conjugate vaccine, PsA-TT (MenAfriVac), developed through the Meningitis Vaccine Project and manufactured by the Serum Institute of India, Ltd, was tested in multiple clinical trials conducted mainly in Africa. The impact of age at which subjects were vaccinated o...

Full description

Bibliographic Details
Main Authors:	Tang, Yuxiao, Plikaytis, Brian D., Preziosi, Marie-Pierre, Borrow, Ray
Format:	Online
Language:	English
Published:	Oxford University Press 2015
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4639503/

id	pubmed-4639503
recordtype	oai_dc
spelling	pubmed-46395032015-11-12 Influence of Age on Antibody Response and Persistence Following Immunization With MenAfriVac Tang, Yuxiao Plikaytis, Brian D. Preziosi, Marie-Pierre Borrow, Ray The Meningitis Vaccine Project: The Development, Licensure, Introduction, and Impact of a New Group a Meningococcal Conjugate Vaccine for Africa Background. A meningococcal group A conjugate vaccine, PsA-TT (MenAfriVac), developed through the Meningitis Vaccine Project and manufactured by the Serum Institute of India, Ltd, was tested in multiple clinical trials conducted mainly in Africa. The impact of age at which subjects were vaccinated on immune response and persistence postimmunization with PsA-TT was the main focus of the current analysis. Oxford University Press 2015-11-15 2015-11-09 /pmc/articles/PMC4639503/ /pubmed/26553685 http://dx.doi.org/10.1093/cid/civ601 Text en © The Author 2015. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
repository_type	Open Access Journal
institution_category	Foreign Institution
institution	US National Center for Biotechnology Information
building	NCBI PubMed
collection	Online Access
language	English
format	Online
author	Tang, Yuxiao Plikaytis, Brian D. Preziosi, Marie-Pierre Borrow, Ray
spellingShingle	Tang, Yuxiao Plikaytis, Brian D. Preziosi, Marie-Pierre Borrow, Ray Influence of Age on Antibody Response and Persistence Following Immunization With MenAfriVac
author_facet	Tang, Yuxiao Plikaytis, Brian D. Preziosi, Marie-Pierre Borrow, Ray
author_sort	Tang, Yuxiao
title	Influence of Age on Antibody Response and Persistence Following Immunization With MenAfriVac
title_short	Influence of Age on Antibody Response and Persistence Following Immunization With MenAfriVac
title_full	Influence of Age on Antibody Response and Persistence Following Immunization With MenAfriVac
title_fullStr	Influence of Age on Antibody Response and Persistence Following Immunization With MenAfriVac
title_full_unstemmed	Influence of Age on Antibody Response and Persistence Following Immunization With MenAfriVac
title_sort	influence of age on antibody response and persistence following immunization with menafrivac
description	Background. A meningococcal group A conjugate vaccine, PsA-TT (MenAfriVac), developed through the Meningitis Vaccine Project and manufactured by the Serum Institute of India, Ltd, was tested in multiple clinical trials conducted mainly in Africa. The impact of age at which subjects were vaccinated on immune response and persistence postimmunization with PsA-TT was the main focus of the current analysis.
publisher	Oxford University Press
publishDate	2015
url	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4639503/
_version_	1613499264087883776

Influence of Age on Antibody Response and Persistence Following Immunization With MenAfriVac

Similar Items